secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTENSITY THERAPEUTICS, INC. (INTS)
CIK:        0001567264
Form:       8-K
Filed at:   2026-02-13T23:59:59+00:00
Accession:  0001567264-26-000007
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intensity Therapeutics to effect 1-for-25 reverse stock split on Feb 18 to meet Nasdaq bid price rule
--------------------------------------------------------------------------------

- Reverse split at 1-for-25 effective 4:01 p.m. ET Feb 18, 2026; post-split trading begins Feb 19.
- Pre-split shares ~63,346,579; post-split ~2,533,863; authorized shares unchanged.
- Purpose is to regain compliance with Nasdaq's $1.00 minimum bid price requirement.
- No fractional shares issued; cash payment in lieu at closing price on Feb 18, adjusted for split.
- Stock symbol remains INTS; new CUSIP 45828J 202.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567264/000156726426000007/0001567264-26-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567264/000156726426000007/intensity-20260213.htm
  HTML page:      https://secwatch.observer/filing/0001567264-26-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer